Dry Eyes: When to See a Doctor and What It Could Mean

What Dry Eye Disease Actually Is

Dry eye disease (DED) is a multifactorial condition of the ocular surface where the tear film loses stability, triggering inflammation and potential damage to the corneal and conjunctival epithelium. The Tear Film and Ocular Surface Society (TFOS) DEWS II report defines it as a disease "characterized by a loss of homeostasis of the tear film" accompanied by ocular symptoms [1]. That definition matters because it shifted the clinical understanding away from simple "not enough tears" toward a disease driven by tear instability and inflammation.

Two Subtypes of Dry Eye

Clinicians classify DED into two broad categories: aqueous-deficient dry eye, where the lacrimal glands produce insufficient tear volume, and evaporative dry eye, where tears evaporate too quickly from the ocular surface. Evaporative dry eye accounts for roughly 85% of all cases [2]. The most common driver of the evaporative form is meibomian gland dysfunction (MGD), a chronic abnormality of the oil-producing glands in the eyelids.

How Common Is It?

A 2022 population-based analysis published in JAMA Ophthalmology estimated that 16.4 million U.S. Adults aged 18 and older have received a dry eye diagnosis, with prevalence climbing to 11.1% among women over age 50 [3]. These figures likely undercount the true burden. Many people attribute their symptoms to allergies, fatigue, or screen strain and never seek care.

Causes and Risk Factors

Dry eye rarely has a single trigger. The condition typically results from overlapping environmental, hormonal, pharmacological, and systemic factors that destabilize the tear film over weeks or months.

Screen Time and Environment

Blink rate drops from a normal 15 to 20 blinks per minute to as few as 3 to 4 blinks per minute during concentrated screen use [4]. Each incomplete blink leaves the inferior cornea exposed, accelerating evaporation. Air conditioning, forced-air heating, airplane cabins, and arid climates compound the problem.

Medications That Dry the Eyes

More than 200 systemic medications list dry eye as a side effect. The most frequent offenders include antihistamines (cetirizine, diphenhydramine), SSRIs (sertraline, fluoxetine), beta-blockers (atenolol, metoprolol), isotretinoin, and anticholinergics used for overactive bladder [5]. If symptoms started within weeks of beginning a new medication, that timing is worth reporting to your prescriber.

Hormonal and Systemic Links

Estrogen and androgen fluctuations directly affect lacrimal and meibomian gland function. Dry eye prevalence spikes during perimenopause and postmenopause, during pregnancy, and among users of oral contraceptives [6]. Systemic autoimmune conditions add another layer. Sjögren syndrome, the second most common autoimmune rheumatic disease, causes lymphocytic infiltration of the lacrimal and salivary glands. The American College of Rheumatology (ACR) 2016 classification criteria estimate that 0.5% to 1% of the general population has Sjögren syndrome, with a 9:1 female-to-male ratio [7].

Diabetes also increases risk. A meta-analysis of 26 studies in Cornea found that patients with diabetes mellitus had a 54% higher pooled odds of DED compared with nondiabetic controls (OR 1.54, 95% CI 1.30 to 1.82) [8].

When to See a Doctor: The Red Flags

Not every episode of gritty, tired eyes demands an appointment. Brief dryness after a long flight or an allergy flare usually resolves with lubricating drops and rest. But certain patterns should prompt a visit.

The Two-Week Rule

If artificial tears used 4 or more times daily fail to resolve symptoms within 14 days, schedule an appointment with an optometrist or ophthalmologist. Persistent symptoms may indicate an inflammatory cycle that over-the-counter drops cannot break.

Symptoms That Need Prompt Evaluation

See a doctor within days (not weeks) if you experience any of the following: significant eye pain rather than mild irritation, sudden or progressive blurred vision that does not clear with blinking, marked redness in one or both eyes, mucous or purulent discharge, sensitivity to light that limits daily activities, or a gritty foreign body sensation that worsens despite lubrication. These signs can overlap with corneal ulceration, anterior uveitis, or acute angle-closure glaucoma, all of which require different treatment [9].

Dry Eyes Plus Joint Pain or Dry Mouth

This combination raises suspicion for Sjögren syndrome. The Sjögren's Foundation recommends evaluation when dry eye coexists with dry mouth lasting more than three months, recurrent salivary gland swelling, or unexplained joint pain [10]. Early diagnosis matters because untreated Sjögren syndrome carries a higher risk of lymphoma and systemic organ involvement.

How Dry Eye Is Diagnosed

A thorough dry eye workup goes well beyond the standard "read the chart" vision test. Your eye care provider will combine symptom questionnaires with objective measurements of tear quantity, quality, and ocular surface integrity.

Symptom Questionnaires

The Ocular Surface Disease Index (OSDI) is a validated 12-item questionnaire that scores symptom severity from 0 (no disease) to 100 (severe disease). Scores of 13 to 22 indicate mild DED, 23 to 32 indicate moderate DED, and scores above 33 indicate severe disease [11]. The OSDI takes about two minutes to complete and gives your clinician a reproducible baseline for tracking treatment response.

Tear Film Tests

The Schirmer test measures aqueous tear production by placing a small filter paper strip inside the lower eyelid for five minutes. A wetting length of <10 mm suggests aqueous deficiency, and <5 mm is considered diagnostic [12]. Tear breakup time (TBUT) evaluates tear film stability. After instilling fluorescein dye, the examiner measures how many seconds the tear film remains intact under a slit lamp. A TBUT of <10 seconds is abnormal.

Advanced Diagnostics

Tear osmolarity testing (TearLab) measures the salt concentration of tears. Values above 308 mOsm/L, or an inter-eye difference greater than 8 mOsm/L, support a DED diagnosis [13]. Meibography uses infrared imaging to photograph the meibomian glands through the eyelid, revealing gland dropout or truncation that correlates with evaporative dry eye. Point-of-care MMP-9 testing (InflammaDry) detects elevated matrix metalloproteinase-9 in tears, a marker of ocular surface inflammation.

Treatments That Work

Dry eye management follows a stepwise approach. The TFOS DEWS II management algorithm recommends starting with education, environmental modification, and artificial tears before escalating to prescription anti-inflammatory therapy, then procedural interventions [14].

Step 1: Lubricants and Lifestyle

Preservative-free artificial tears remain first-line therapy. Preserved formulations containing benzalkonium chloride (BAK) can worsen epithelial toxicity when used more than 4 times daily [15]. Lipid-based drops (such as Systane Complete or Refresh Optive Mega-3) may work better for evaporative dry eye because they supplement the deficient lipid layer.

The 20-20-20 rule provides a simple behavioral intervention: every 20 minutes, look at something 20 feet away for 20 seconds. Humidifying indoor air to 40% to 60% relative humidity, and positioning screens slightly below eye level, also reduces evaporative stress.

Step 2: Prescription Anti-Inflammatory Drops

When lubricants alone are insufficient, two FDA-approved topical immunomodulators target the inflammatory component of DED. Cyclosporine 0.05% ophthalmic emulsion (Restasis) demonstrated a statistically significant increase in Schirmer scores versus vehicle at 6 months in its key Phase III trials (P < 0.05), though the clinical magnitude of improvement was modest at roughly 10 mm of additional wetting [16]. Lifitegrast 5% ophthalmic solution (Xiidra) blocks lymphocyte function-associated antigen-1 (LFA-1) and showed significant improvement in the eye dryness score (EDS) versus placebo at 12 weeks in the OPUS-2 (N=718) and OPUS-3 (N=711) trials [17].

Dr. Anat Galor, a dry eye specialist at the Miami VA Medical Center and Bascom Palmer Eye Institute, has noted: "The biggest shift in dry eye management over the past decade is recognizing the inflammatory component early. Waiting until the cornea is staining heavily means you've missed the optimal treatment window" [18].

Step 3: Procedures and Devices

For moderate-to-severe MGD, in-office thermal pulsation (LipiFlow) applies controlled heat and pressure to the eyelids to express obstructed meibomian glands. A randomized trial of 200 eyes showed LipiFlow produced significantly greater improvement in meibomian gland secretion scores compared with warm compresses at 12 months [19]. Intense pulsed light (IPL) therapy applied to the periorbital skin has also shown benefit for MGD-related evaporative dry eye, though it remains off-label for this indication.

Punctal plugs, small silicone or collagen devices inserted into the tear drainage ducts, reduce tear outflow and keep existing tears on the surface longer. They work best in aqueous-deficient dry eye after inflammation has been controlled.

Newer Options

Varenicline nasal spray 0.03 mg (Tyrvaya), approved by the FDA in 2021, stimulates the trigeminal parasympathetic pathway to increase both aqueous and lipid tear production. The ONSET-2 trial (N=758) showed a statistically significant improvement in Schirmer scores at week 4 compared with placebo [20]. This mechanism is distinct from anti-inflammatory drops and offers a non-ocular route of administration.

The Role of Nutrition and Supplements

The relationship between omega-3 fatty acids and dry eye has produced mixed evidence, but the balance of data supports a modest benefit.

Omega-3 Fatty Acids

The Dry Eye Assessment and Management (DREAM) Study, a large NIH-funded multicenter trial (N=535), found that omega-3 supplementation (3,000 mg/day of EPA + DHA) did not show statistically significant benefit over olive oil placebo at 12 months on the OSDI [21]. That result surprised many clinicians. However, critics noted the olive oil control itself has anti-inflammatory properties, potentially masking a true treatment effect. Earlier, smaller trials and a 2019 Cochrane review of 34 RCTs concluded that omega-3 supplementation "probably" improves dry eye symptoms and signs compared with placebo (moderate-certainty evidence) [22].

Other Nutritional Factors

Vitamin A deficiency causes keratinization of the ocular surface and remains a leading cause of dry eye in low-income countries, though it is rare in the U.S. Adequate hydration (a minimum of 2 liters of fluid daily for most adults) supports systemic mucous membrane health, including the tear film.

Dry Eyes and Contact Lenses

Contact lens wear is one of the most common modifiable risk factors for dry eye. An estimated 50% of contact lens wearers report dry eye symptoms [23]. The lens disrupts the tear film's lipid layer and increases evaporation. Scleral lenses, which vault over the cornea and hold a reservoir of saline against the ocular surface, can serve as both a vision correction and a therapeutic device for severe dry eye. Daily disposable lenses generally produce fewer dry eye symptoms than extended-wear lenses because they eliminate deposit buildup.

The TFOS International Workshop on Contact Lens Discomfort, chaired by Dr. Jason Nichols at the University of Alabama at Birmingham, concluded: "Contact lens discomfort is a condition characterized by episodic or persistent adverse ocular sensations related to lens wear, and its management should address both the tear film and the lens material" [24].

Conditions That Mimic Dry Eye

Several ocular and systemic conditions produce symptoms that overlap with dry eye, which is one reason a professional evaluation matters.

Allergic Conjunctivitis

Itching is the hallmark that distinguishes ocular allergy from dry eye. Seasonal allergic conjunctivitis also tends to produce watery rather than scanty tears. However, the two conditions frequently coexist, and antihistamine drops used for allergy can worsen dryness.

Blepharitis

Anterior blepharitis (inflammation of the eyelid margin around the lash base) and posterior blepharitis (meibomian gland dysfunction) both cause burning, foreign body sensation, and crusting. Blepharitis is best understood as a contributor to dry eye rather than a mimic. Lid hygiene with warm compresses and hypochlorous acid sprays forms the foundation of treatment.

Neurotrophic Keratopathy

Reduced corneal sensation from herpes simplex, herpes zoster, diabetes, or post-surgical nerve damage decreases reflex tearing and blinking. Patients with neurotrophic keratopathy may have minimal subjective symptoms despite significant corneal surface damage, making the condition easy to miss without corneal sensitivity testing.

What to Expect at Your First Visit

An initial dry eye evaluation typically lasts 30 to 45 minutes and includes a detailed history (symptom duration, medications, screen habits, systemic conditions), slit-lamp examination with fluorescein and lissamine green staining, TBUT measurement, and possibly Schirmer testing. Some practices perform tear osmolarity and meibography at the first visit. Expect to leave with a treatment plan that starts conservatively. Most clinicians reassess at 4 to 6 weeks to determine whether escalation is needed.

Bring a current medication list, including supplements and over-the-counter drops you have already tried. Note how many hours per day you spend on screens. If dry mouth, joint pain, or skin changes accompany your eye symptoms, mention them. That context can redirect the workup toward systemic causes.